Jefferies Group LLC Fibrogen Inc Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Jefferies Group LLC holds 35,000 shares of FGEN stock, worth $389,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,000

Holding current value

$389,900

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $144,472 - $185,025	-12,673 Reduced 91.81%	1,130 $1,000
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $109,595 - $178,886	13,803 New	13,803 $2,000
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $140,910 - $196,829	-11,723 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $116,409 - $180,416	11,723 New	11,723 $72,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $170,657 - $446,592	-16,764 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$18.57 - $35.68 $290,323 - $557,821	15,634 Added 1383.54%	16,764 $446,000
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $51,476 - $98,904	-2,772 Reduced 14.19%	16,764 $446,000
Q1 2020 May 15, 2020	BUY	$23.3 - $45.96 $163,938 - $323,374	7,036 Added 56.29%	19,536 $679,000
Q4 2019 Feb 13, 2020	BUY	$34.58 - $48.06 $14,385 - $19,992	416 Added 3.44%	12,500 $536,000
Q3 2019 Nov 13, 2019	BUY	$36.98 - $48.45 $446,866 - $585,469	12,084 New	12,084 $447,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

Call Options Held

35K

Put Options Held

Black Rock Inc. New York, NY

2.41M
Shares

$26.8 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

1.37M
Shares

$15.3 Million
0.0% of portfolio
Intercontinental Wealth Advisors, LLC

95.7K
Shares

$1.07 Million
0.06% of portfolio
Eaton Vance Management Boston, MA

94.5K
Shares

$1.05 Million
0.0% of portfolio
Connective Capital Management, LLC Palo Alto, CA

15K
Shares

$167,100
0.07% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $1.04B
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account